Moderna has joined the S&P 500 – and it’s now the index’s best-performing stock this year. But history has shown that becoming a member of… Read More »Is Moderna’s Inclusion In The S&P 500 Bullish Or Bearish?
What impact would waiving patent protections for COVID-19 vaccines – a move the Biden administration has expressed support for – have on biotech stocks? Potentially… Read More »Biotech Profits & The COVID Vaccine Patent Battle
With the distribution of COVID-19 vaccines underway, investors have begun rotating out of pricey tech growth stocks and into cheaper non-tech value stocks. With this… Read More »4 Stocks For The Rotation From Tech/Growth To Non-Tech/Value
In a post-vaccine world, some of the emerging markets that have been hardest hit by the coronavirus pandemic are likely to stage the biggest recoveries… Read More »These Emerging Market Stocks Could Emerge As Winners In A Post-Vaccine World